Literature DB >> 34717065

The Role of Pulmonary Artery Wedge Pressure on the Incidence of Atrial Fibrillation and Atrial Tachycardias in Patients With Isolated Pre-capillary Pulmonary Hypertension.

M Dusik1, Z Fingrova, D Ambroz, P Jansa, A Linhart, S Havranek.   

Abstract

Atrial fibrillation and atrial tachycardias (AF/AT) have been reported as a common condition in patients with pulmonary hypertension (PH). As yet, limited data exists about the significance of the borderline post-capillary pressure component on the occurrence of AF / AT in patients with isolated pre-capillary PH. We retrospectively studied the prevalence of AF / AT in 333 patients (mean age 61 ± 15 years, 44% males) with pre-capillary idiopathic / familiar pulmonary arterial hypertension, and inoperable chronic thromboembolic pulmonary hypertension. The prevalence of AF / AT was analyzed in different categories of pulmonary artery wedge pressure (PAWP). In the study population overall, the mean PAWP was 10.5 ± 3 mmHg, median of 11 mmHg, range 2-15 mmHg. AF / AT was diagnosed in 79 patients (24%). The proportion of AF / AT among patients with PAWP below the median (?11 mmHg) was lower than in subjects with PAWP between 12 and 15 mmHg, 30 (16%) vs. 46 (35%), p = 0.0001. Compared to the patients with PAWP?11 mmHg, subjects with PAWP between 12 and 15 mmHg were older (65 ± 13 years vs. 58 ± 16), with more prevalent arterial hyperte\nsion [100 (70%) vs. 106 (55%)] and diabetes mellitus [50 (35%) vs. 48 (25%)], showed larger size of the left atrium (42 ± 7 vs. 40 ± 6 mm), and higher values of right atrium pressure (12 ± 5 vs. 8 ± 5 mm Hg), p < 0.05 in all comparisons. The prevalence of AF / AT in the group studied increased with the growing post-capillary component.

Entities:  

Mesh:

Year:  2021        PMID: 34717065      PMCID: PMC8815468          DOI: 10.33549/physiolres.934706

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  27 in total

1.  Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.

Authors:  Nazzareno Galiè; Adam Torbicki; Robyn Barst; Philippe Dartevelle; Sheila Haworth; Tim Higenbottam; Horst Olschewski; Andrew Peacock; Giuseppe Pietra; Lewis J Rubin; Gerald Simonneau; Silvia G Priori; Maria Angeles Alonso Garcia; Jean-Jacques Blanc; Andrzej Budaj; Martin Cowie; Verconcia Dean; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; Keith McGregor; João Morais; Ali Oto; Otto A Smiseth; Joan Albert Barbera; Simon Gibbs; Marius Hoeper; Marc Humbert; Robert Naeije; Joanna Pepke-Zaba
Journal:  Eur Heart J       Date:  2004-12       Impact factor: 29.983

2.  Right atrial size and function in patients with pulmonary hypertension associated with disorders of respiratory system or hypoxemia.

Authors:  Giovanni Cioffi; Giovanni de Simone; Gianfrancesco Mureddu; Luigi Tarantini; Carlo Stefenelli
Journal:  Eur J Echocardiogr       Date:  2006-07-28

Review 3.  Initiating reentry: the role of nonuniform anisotropy in small circuits.

Authors:  M S Spach; M E Josephson
Journal:  J Cardiovasc Electrophysiol       Date:  1994-02

4.  Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat.

Authors:  J Ausma; M Wijffels; F Thoné; L Wouters; M Allessie; M Borgers
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

5.  Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension.

Authors:  Michele D'Alto; Emanuele Romeo; Paola Argiento; Yoshiki Motoji; Anna Correra; Giovanni Maria Di Marco; Agostino Mattera Iacono; Rosaria Barracano; Antonello D'Andrea; Gaetano Rea; Berardo Sarubbi; Maria Giovanna Russo; Robert Naeije
Journal:  Chest       Date:  2016-08-26       Impact factor: 9.410

6.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

7.  Histopathological substrate for chronic atrial fibrillation in humans.

Authors:  Bich Lien Nguyen; Michael C Fishbein; Lan S Chen; Peng-Sheng Chen; Saqib Masroor
Journal:  Heart Rhythm       Date:  2009-01-16       Impact factor: 6.343

8.  Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension.

Authors:  A F Folino; F Bobbo; C Schiraldi; F Tona; S Romano; G Buja; F Bellotto
Journal:  Lung       Date:  2003 Nov-Dec       Impact factor: 2.584

Review 9.  New insights into mechanisms of atrial fibrillation.

Authors:  B Aldhoon; V Melenovský; P Peichl; J Kautzner
Journal:  Physiol Res       Date:  2009-02-27       Impact factor: 1.881

10.  The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension.

Authors:  Zdenka Fingrova; Stepan Havranek; David Ambroz; Pavel Jansa; Ales Linhart
Journal:  BMC Cardiovasc Disord       Date:  2019-06-28       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.